Biotech venture capitalists have increasingly embraced the virtual model, seeding companies with promising assets, tiny staffs and a willingness to outsource. Now, as Reuters notes, a recent Big Pharma buyout signals that the idea is gaining steam among larger players.

…read more

Source: Virtual biotechs a hit with investors and, increasingly, buyers


0 No comments